SEC Form 4 · accession 0001209191-18-036801
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Comcowich
Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 7:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.80 | Jun 6, 2018 | A | 7,476 | A | — | Jun 6, 2028 | Common Stock | 7,476 | 12,890 | D |
Explanation of responses
- F1The Option will become 100% vested and excercisable on the earlier to occur of (i) June 6, 2019 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.